Koskiniemi M, Piiparinen H, Mannonen L, Rantalaiho T, Vaheri A
Haartman Institute, Department of Virology, University of Helsinki, Finland.
J Neurol Neurosurg Psychiatry. 1996 Feb;60(2):174-8. doi: 10.1136/jnnp.60.2.174.
To assess the diagnostic potential of the polymerase chain reaction (PCR) in herpes simplex virus (HSV) encephalitis.
Samples of CSF from 516 patients with encephalitis were studied for HSV-DNA by PCR.
Samples taken one to 29 days from the onset of symptoms from 38 patients (7.4%) were positive, 32 (6.2%) for HSV-1 and six (1.2%) for HSV-2. At follow up, eight of 28 patients studied were still HSV-PCR positive. A diagnostic serum:CSF antibody ratio to HSV but not to other viruses was detected in 25 of the 38 HSV-PCR positive patients thus supporting the initial PCR findings. Patients positive by HSV-PCR were concentrated in the age group > or = 40 years, and especially in patients aged 60-64 years, of whom nine of 24 (37.5%) were positive. The HSV-PCR was negative in all other patients with encephalitis of known or unknown aetiology. This group included 34 patients with a diagnostic serum:CSF antibody ratio to other viruses. A dual infection, HSV and another microbe, was considered possible in seven patients.
The HSV-PCR is a rapid and useful diagnostic method during the early phase of encephalitis. It may be useful in monitoring the efficacy of treatment and allowing the recognition of new features in the appearance of herpes encephalitis. The HSV-PCR test and antibody determinations from serum and CSF are complementary methods, which should both be applied in pursuit of clinical laboratory diagnosis of these conditions.
评估聚合酶链反应(PCR)在单纯疱疹病毒(HSV)脑炎中的诊断潜力。
采用PCR对516例脑炎患者的脑脊液样本进行HSV-DNA检测。
38例(7.4%)患者在症状出现后1至29天采集的样本呈阳性,其中32例(6.2%)为HSV-1阳性,6例(1.2%)为HSV-2阳性。随访时,28例接受研究的患者中有8例HSV-PCR仍为阳性。在38例HSV-PCR阳性患者中的25例检测到针对HSV而非其他病毒的诊断性血清:脑脊液抗体比值,从而支持了最初的PCR检测结果。HSV-PCR阳性患者集中在年龄≥40岁的年龄组,尤其是60 - 64岁的患者,其中24例中有9例(37.5%)呈阳性。所有其他已知或未知病因的脑炎患者HSV-PCR均为阴性。该组包括34例具有针对其他病毒的诊断性血清:脑脊液抗体比值的患者。7例患者可能存在HSV与另一种微生物的双重感染。
HSV-PCR是脑炎早期快速且有用的诊断方法。它可能有助于监测治疗效果并识别疱疹性脑炎出现的新特征。HSV-PCR检测以及血清和脑脊液抗体测定是互补的方法,在这些疾病的临床实验室诊断中均应采用。